This Month in Psychopharmacology

Predicting Substance Use Behaviors with Machine Learning

In a recent study, researchers used a small set of variables and ma...

Read More

A Review of Evidence Reveals Minimal Support for Cannabinoids in Psychiatric Care

Cannabinoids are increasingly promoted and used for the treatment o...

Read More

Psilocybin Shows Greater Efficacy Than Nicotine Patches in Smoking Cessation Pilot Trial

More than two-thirds of U.S. smokers want to quit, but available tr...

Read More

Cannabidiol Fails to Protect Against Cannabis-Induced Symptoms in Schizophrenia

A new study examined whether cannabidiol could mitigate the acute a...

Read More

Patterns of Cannabis and Alcohol Use for Sleep Initiation in Young Adults

Sleep difficulties are widespread in young adults, with some indivi...

Read More

Novel Benzodiazepines Linked to More Severe Opioid Overdoses

The combination of opioids and benzodiazepines poses a growing chal...

Read More

GLP-1 Receptor Agonists for the Treatment of Opioid Use Disorders

Opioid Use Disorder (OUD) remains a major public health crisis, wit...

Read More

Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults

Prescribing stimulants, particularly amphetamines and methylphenida...

Read More

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder

A recent randomized clinical trial provides promising evidence that...

Read More

GLP-1 Agonist for Alcohol Use Disorder

A new study suggests that glucagon-like peptide-1 receptor (GLP-1) ...

Read More

Smoking Cessation as a Priority for Psychiatrists

Smoking rates remain disproportionately high among individuals with...

Read More

Combination OUD Treatment Safe During Pregnancy

A recent study explored the comparative safety of prenatal exposure...

Read More